title: [Surgical outcomes of esophageal cancer resection since the development of an Oesophagogastric Tumour Board].
abstract: BACKGROUND
  Treatment of oesophageal cancer with curative intent requires a multidisciplinary approach. Neoadjuvant therapy, the radicality of resection and extension of lymphadenectomy have been associated with increased operative morbidity and mortality. The aim of this study was to assess the results of surgical treatment of oesophageal cancer since the presence of an interdisciplinary esophagogastric tumour board.
  
  
  METHODS
  Patients with cancer of the oesophagus and oesophagogastric junction who underwent oesophagectomy between January 2005 and March 2012 were included in this retrospective study. Data concerning type of resection, postoperative complications, mortality and survival were analysed.
  
  
  RESULTS
  Of the 392 patients with a diagnosis of oesophageal cancer over the study period, 100 underwent oesophagectomy. Seventy-four patients received neoadjuvant treatment. Eighty-two patients underwent transthoracic resection while a transhiatal was used in 10 patients. Colon interposition was required in 8 cases. An R0 resection was achieved in 98 patients. Anastomotic leaks developed in 15 patients, 9 were intrathoracic and 6 were cervical. Postoperative morbidity occurred in 42% of patients, and intra-hospital and 90-day mortality was 2%. Median length of hospital stay was 16 days. The respective actuarial survival at 1 and 5 years were 82% and 56%.
  
  
  CONCLUSIONS
  Surgical treatment with curative intention for oesophageal cancer is only possible in a quarter of patients diagnosed. The high morbidity rate was mainly due to intrathoracic complications.
authors.affiliation: Unitat de Cirurgia Esofagogàstrica, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España. Electronic address: lfarran@aecirujanos.es.
authors.forename: Leandre
authors.initials: L
authors.lastname: Farran Teixidor
authors.forename: Josep
authors.initials: J
authors.lastname: Llop Talaverón
authors.forename: Maica
authors.initials: M
authors.lastname: Galán Guzmán
authors.forename: Humberto
authors.initials: H
authors.lastname: Aranda Danso
authors.forename: Mónica
authors.initials: M
authors.lastname: Miró Martín
authors.forename: Carla
authors.initials: C
authors.lastname: Bettónica Larrañaga
authors.forename: Fernando
authors.initials: F
authors.lastname: Estremiana García
authors.forename: Sebastiano
authors.initials: S
authors.lastname: Biondo
mesh_terms: D002985:Clinical Protocols; D004938:Esophageal Neoplasms / Q000601:surgery*; D016629:Esophagectomy / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D012189:Retrospective Studies; D013044:Specialty Boards; D016896:Treatment Outcome
keywords: Anastomotic leak; Complicaciones esofagectomía; Cumulative survival; Cáncer de esófago; Dehiscencia anastomosis; Neoadjuvant therapy; Oesophageal cancer; Oesophagectomy; Supervivencia; Tratamiento neoadyuvante